EDGAR Filing Documents for 0001144204-16-133396

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001144204-16-133396

Filing Date

2016-11-10

Accepted

2016-11-10 17:17:05

Documents

Period of Report

2016-11-10

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	v452629_6k.htm	6-K	9514
2	EXHIBIT 99.1	v452629_ex99-1.htm	EX-99.1	383868
	Complete submission text file	0001144204-16-133396.txt		394581

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 161989143
SIC: 2834 Pharmaceutical Preparations